With Amazon entering the telehealth market for hair loss and erectile dysfunction treatments, I anticipate significant margin compression for HIMS. Th...
Read
More
With Amazon entering the telehealth market for hair loss and erectile dysfunction treatments, I anticipate significant margin compression for HIMS. The efficiency and reach of Amazon could lead to a decline in HIMS' market share, making it suitable for a short position in the near term.
I believe HIMS is on the verge of explosive growth with a promising market position in telehealth. The macro environment looks supportive, and conside...
Read
More
I believe HIMS is on the verge of explosive growth with a promising market position in telehealth. The macro environment looks supportive, and considering their projected 90%+ growth in Q4, I'm confident that these January 2026 calls will pay off handsomely.
I'm adding more shares of HIMS because I believe it's headed for $40 by mid-2025. The last earnings report showed massive growth, which gives me confi...
Read
More
I'm adding more shares of HIMS because I believe it's headed for $40 by mid-2025. The last earnings report showed massive growth, which gives me confidence in this stock's upward trajectory in the near future.
I just bought some call options for HIMS at the $20 strike. With a 700% EPS beat and potential upside from election-related movements, I believe the s...
Read
More
I just bought some call options for HIMS at the $20 strike. With a 700% EPS beat and potential upside from election-related movements, I believe the stock is positioned to recover and break out in the coming days.
Just saw HIMS beat their earnings by 700% and they barely moved. This makes me think there's potential for a solid rebound, so I'm looking to scoop up...
Read
More
Just saw HIMS beat their earnings by 700% and they barely moved. This makes me think there's potential for a solid rebound, so I'm looking to scoop up some shares. I'm all in on HIMS for a nice swing here.
With the recent news that Ozempic is no longer in shortage, I believe HIMS is facing challenges ahead as their primary growth driver diminishes. The m...
Read
More
With the recent news that Ozempic is no longer in shortage, I believe HIMS is facing challenges ahead as their primary growth driver diminishes. The market's strong reaction indicates a potential drop, and I'm looking to take a short position to capitalize on this shift.
I just stacked 3573 shares of HIMS and I plan to add more soon. With my cost basis at €14.91, I see solid potential for this stock to move up, especia...
Read
More
I just stacked 3573 shares of HIMS and I plan to add more soon. With my cost basis at €14.91, I see solid potential for this stock to move up, especially given the recent buzz around the company.
I believe HIMS is on the brink of a major breakout with upcoming earnings and new product announcements. With GLP1 fears pushed back and a lack of rec...
Read
More
I believe HIMS is on the brink of a major breakout with upcoming earnings and new product announcements. With GLP1 fears pushed back and a lack of recent positive catalysts, I expect significant upside potential in the coming weeks, making it a great play for call options.
With impressive 52% revenue growth and a solid full-year revenue guidance of $1.37-1.4 billion, I believe Hims has the potential to maintain its marke...
Read
More
With impressive 52% revenue growth and a solid full-year revenue guidance of $1.37-1.4 billion, I believe Hims has the potential to maintain its market position despite competitive pressures. Their unique brand appeal and personalized services seem to attract a loyal customer base that values discretion and ease of access.
I believe HIMS is primed for a significant upside as recent developments suggest legal threats from Lilly have been mitigated. With a strong growth tr...
Read
More
I believe HIMS is primed for a significant upside as recent developments suggest legal threats from Lilly have been mitigated. With a strong growth trajectory and new product launches on the horizon, now seems to be the perfect time to get in before the potential rally.
I'm planning to buy HIMS shares now that it's joining the S&P small cap 600. The elevation in status should drive demand and help it jump significantl...
Read
More
I'm planning to buy HIMS shares now that it's joining the S&P small cap 600. The elevation in status should drive demand and help it jump significantly in value, making this a solid long-term hold in my portfolio.
Despite some confusion about the option pricing glitch, I see strong potential in HIMS. The price hasn’t dropped significantly and that 10% gain today...
Read
More
Despite some confusion about the option pricing glitch, I see strong potential in HIMS. The price hasn’t dropped significantly and that 10% gain today indicates bullish sentiment. Holding my call options could pay off if the stock trends upwards in the upcoming weeks.
I'm really bullish on HIMS after seeing their latest revenue growth and subscriber numbers. Despite some insider selling, I believe their business mod...
Read
More
I'm really bullish on HIMS after seeing their latest revenue growth and subscriber numbers. Despite some insider selling, I believe their business model has strong potential for sustained growth, and I'm looking to ride this upward trend over the next few months.